Mesothelioma News and Research

RSS
Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.
Mesothelioma patients twice as likely to survive when treated with high dose of radiation

Mesothelioma patients twice as likely to survive when treated with high dose of radiation

Research demonstrates clinical utility of ddPCR-powered liquid biopsy at 2019 AACR Annual Meeting

Research demonstrates clinical utility of ddPCR-powered liquid biopsy at 2019 AACR Annual Meeting

New combination therapy found to be well tolerated in patients with aggressive brain tumor

New combination therapy found to be well tolerated in patients with aggressive brain tumor

World's largest AI-powered medical research network launched by OWKIN

World's largest AI-powered medical research network launched by OWKIN

Researchers discover new mechanism behind spread of malignant pleural mesothelioma

Researchers discover new mechanism behind spread of malignant pleural mesothelioma

Asbestos found in most NHS hospitals finds BBC inquiry

Asbestos found in most NHS hospitals finds BBC inquiry

People with rare cancers can benefit from genomic profiling, shows research

People with rare cancers can benefit from genomic profiling, shows research

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

New discovery links proteins that control DNA packaging and cancer development

New discovery links proteins that control DNA packaging and cancer development

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Researchers find how NF2 gene mutations lead to out-of-control cellular proliferation

Researchers find how NF2 gene mutations lead to out-of-control cellular proliferation

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Study finds increase in lifestyle-related cancers over the past decade

Study finds increase in lifestyle-related cancers over the past decade

International researchers succeed in stopping growth of mesothelioma in model animals

International researchers succeed in stopping growth of mesothelioma in model animals

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Molecular inhibitors found to arrest tumor cell proliferation in lung cancer and mesothelioma

Molecular inhibitors found to arrest tumor cell proliferation in lung cancer and mesothelioma

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Study findings could lead to less expensive and more effective cancer treatments

Study findings could lead to less expensive and more effective cancer treatments

Novel approach could help predict how well patients respond to cancer treatment

Novel approach could help predict how well patients respond to cancer treatment